Day: November 18, 2022

TJP Labs Inc. Amends Its Drug Establishment License and Achieves Approval for Active Pharmaceutical Ingredients

PICKERING, Ontario, Nov. 17, 2022 (GLOBE NEWSWIRE) — TJP Labs Inc. (“TJP Labs”) is North America’s leading full-service contract manufacturer of premier next-generation products, focusing on modern oral nicotine pouches and oral delivery solutions for caffeine and other nutraceutical products. Today, TJP Labs announced that after completing a thorough regulatory

Read more

Recent News